老年急性胰腺炎患者预后模型的开发与验证
本研究为回顾性队列研究,纳入2015年1月至2024年12月遵义医科大学附属医院收治的2569例年龄≥60岁急性胰腺炎患者,按7:3随机分为训练集(1801例,死亡177例,9.8%)和验证集(768例,死亡69例,9.0%)。采用Lasso回归筛选变量后行多因素Logistic回归,确定年龄、Ranson评分、AST、ARDS及使用血管活性药物为独立预测因素,并构建列线图模型。训练集AUC为0.817(95%CI 0.784-0.851),验证集AUC为0.823(95%CI 0.775-0.871),校准曲线显示预测概率与观察概率一致性良好,DCA显示在较宽阈值概率范围内具有良好净临床获益。该模型可为老年急性胰腺炎患者提供个体化预后评估工具。
要点
- 年龄(OR=1.076,95%CI 1.054-1.099)、Ranson评分(OR=1.318,95%CI 1.215-1.429)、AST(OR=1.001,95%CI 1.000-1.001)、ARDS(OR=3.782,95%CI 2.495-5.732)及使用血管活性药物(OR=4.850,95%CI 3.192-7.370)为老年急性胰腺炎院内死亡的独立预测因素。
- 列线图模型训练集AUC 0.817(95%CI 0.784-0.851),验证集AUC 0.823(95%CI 0.775-0.871), discriminative ability良好。
- 校准曲线显示预测概率与观察概率一致性良好,DCA显示在较宽阈值概率范围内具有良好净临床获益。
- 该模型可为老年急性胰腺炎患者提供个体化预后评估工具,辅助临床决策。
适用人群与场景
- 年龄≥60岁、于2015年1月至2024年12月就诊于遵义医科大学附属医院并诊断为急性胰腺炎的患者。
研究设计与关键结果
- 回顾性队列研究,纳入2569例老年急性胰腺炎患者,其中院内生存2323例、死亡246例;训练集1801例(死亡177例,9.8%),验证集768例(死亡69例,9.0%)。
- Lasso回归筛选出年龄、Ranson评分、AST、ARDS及使用血管活性药物5个候选变量。
- 多因素Logistic回归显示年龄(OR=1.076,95%CI 1.054-1.099,P<0.001)、Ranson评分(OR=1.318,95%CI 1.215-1.429,P<0.001)、AST(OR=1.001,95%CI 1.000-1.001,P<0.001)、ARDS(OR=3.782,95%CI 2.495-5.732,P<0.001)及使用血管活性药物(OR=4.850,95%CI 3.192-7.370,P<0.001)为院内死亡的独立预测因素。
- 基于上述5个因素构建列线图模型,训练集AUC 0.817(95%CI 0.784-0.851),验证集AUC 0.823(95%CI 0.775-0.871)。
- 校准曲线显示预测概率与观察概率一致性良好;DCA显示在较宽阈值概率范围内具有良好净临床获益。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该列线图模型可用于老年急性胰腺炎患者院内死亡的个体化预后评估,作者认为其可为临床决策提供参考。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To identify independent predictors of in-hospital mortality in elderly patients with acute pancreatitis (AP) and to develop and validate a nomogram prediction model.
METHODS: A retrospective cohort study was conducted, including patients aged ≥ 60 years admitted to the Affiliated Hospital of Zunyi Medical University with a diagnosis of AP from January 2015 to December 2024. Based on in-hospital outcomes, patients were divided into survival and death groups and were then randomly allocated to a training set and a validation set in a 7 : 3 ratio. Predictors were initially screened using Lasso regression and subsequently entered into multivariate Logistic regression analysis to identify independent risk factors for constructing the nomogram. Model discrimination, calibration, and clinical utility were evaluated using the receiver operator characteristic curve (ROC curve), calibration curve, and decision curve analysis (DCA), respectively.
RESULTS: A total of 2 569 elderly AP patients were enrolled, with 2 323 survivors and 246 deaths in the hospital. The training set contained 1 801 patients (177 deaths, 9.8%), and the validation set contained 768 patients (69 deaths, 9.0%). Lasso regression identified five candidate variables including age, Ranson score, aspartate aminotransferase (AST), acute respiratory distress syndrome (ARDS), and use of vasoactive agents. Multivariate Logistic regression showed that age [odds ratio (OR) = 1.076, 95% confidence interval (95%CI) was 1.054-1.099, P < 0.001], Ranson score (OR = 1.318, 95%CI was 1.215-1.429, P < 0.001), AST (OR = 1.001, 95%CI was 1.000-1.001, P < 0.001), ARDS (OR = 3.782, 95%CI was 2.495-5.732, P < 0.001), and use of vasoactive agents (OR = 4.850, 95%CI was 3.192-7.370, P < 0.001) were independent predictors of in-hospital mortality. The nomogram prediction model was constructed based on the above five factors, ROC curve analysis shows that, the area under the curve (AUC) was 0.817 (95%CI was 0.784-0.851) in the training set and 0.823 (95%CI was 0.775-0.871) in the validation set, indicating good discriminative ability. Calibration plots demonstrated good agreement between predicted and observed probabilities, and DCA showed favorable net clinical benefit across a wide range of threshold probabilities.
CONCLUSIONS: The nomogram incorporating five independent predictors-age, Ranson score, AST, ARDS, and use of vasoactive agents-demonstrated good predictive performance for in-hospital mortality among elderly AP patients. This model provides a practical tool for individualized prognostic assessment and for informing clinical decision-making in this population.
参考来源
- Gong M, He H, Wang J, et al. [Development and validation of a prognostic model for elderly patients with acute pancreatitis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 41437587. doi:10.3760/cma.j.cn121430-20250622-00597
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。